- Home
- DNTH vs TIGR Comparison
DNTH vs TIGR Comparison
Compare DNTH & TIGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNTH | TIGR |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.5B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | DNTH | TIGR |
|---|---|---|
| Price | $51.68 | $8.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $70.22 | $14.20 |
| AVG Volume (30 Days) | 931.1K | ★ 4.2M |
| Earning Date | 03-10-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 328.15 |
| EPS | N/A | ★ 0.82 |
| Revenue | $3,078,000.00 | ★ $489,538,356.00 |
| Revenue This Year | N/A | $79.26 |
| Revenue Next Year | N/A | $5.17 |
| P/E Ratio | ★ N/A | $10.19 |
| Revenue Growth | N/A | ★ 76.50 |
| 52 Week Low | $13.37 | $6.38 |
| 52 Week High | $57.50 | $13.55 |
Technical Indicators
Market Signals| Indicator | DNTH | TIGR |
|---|---|---|
| Relative Strength Index (RSI) | 64.09 | 36.18 |
| Support Level | $48.86 | $8.60 |
| Resistance Level | $57.50 | $8.88 |
| Average True Range (ATR) | 3.13 | 0.38 |
| MACD | 0.51 | -0.10 |
| Stochastic Oscillator | 61.47 | 16.79 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About TIGR UP Fintech Holding Ltd representing fifteen
UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.